Public-registry site landscape for NCT04819269, a Dry Eye Disease study sponsored by Sylentis, S.A.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04819269 (registry record) |
| Sponsor | Sylentis, S.A. |
| Condition(s) | Dry Eye Disease; Sjögren Syndrome |
| Phase | PHASE3 |
| Listed sites | 46 |
| Site countries | United States, Spain |
Eichor generates a preliminary site-risk snapshot for NCT04819269 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →